Group One Trading
KITE

Group One Trading’s Kite Pharma, Inc. KITE Stock Holding History

Group One Trading’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-133,900
Closed -$24.1M – 5612
2017
Q3 		$24.1M Sell
133,900
-22,000
-14% -$3.07M 0.22% 80
2017
Q2 		$16.2M Buy
155,900
+63,300
+68% +$5.17M 0.17% 115
2017
Q1 		$7.27M Buy
92,600
+73,100
+375% +$4.52M 0.08% 276
2016
Q4 		$874K Sell
19,500
-55,600
-74% -$2.73M 0.01% 1403
2016
Q3 		$4.2M Buy
75,100
+66,300
+753% +$3.69M 0.05% 487
2016
Q2 		$440K Buy
8,800
+8,500
+2,833% +$418K 0.01% 1830
2016
Q1 		$14K Sell
300
-12,300
-98% -$596K ﹤0.01% 3913
2015
Q4 		$776K Sell
12,600
-10,000
-44% -$704K 0.01% 1492
2015
Q3 		$1.26M Buy
22,600
+5,500
+32% +$346K 0.02% 1080
2015
Q2 		$1.04M Sell
17,100
-14,200
-45% -$810K 0.01% 1169
2015
Q1 		$1.8M Buy
31,300
+19,700
+170% +$1.32M 0.03% 695
2014
Q4 		$669K Buy
+11,600
New +$488K 0.01% 1338

Group One Trading's KITE Position: Q3 2017 in Review

Group One Trading sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 32,877 shares — an estimated $4.58M sold.

Group One Trading first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $3.41M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Group One Trading reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 32,877 Kite Pharma, Inc. shares in Q3 2017, an estimated $4.58M.
  • Group One Trading first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
  • Group One Trading's Kite Pharma, Inc. position peaked at $3.41M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.